Clinical Significance of Focal Adhesion Kinase in Resectable Pancreatic Cancer
- 21 January 2006
- journal article
- research article
- Published by Wiley in World Journal of Surgery
- Vol. 30 (2), 219-226
- https://doi.org/10.1007/s00268-005-0165-z
Abstract
Focal adhesion kinase (FAK) is a non-receptor, cytoplasmic protein tyrosine kinase that is involved in the regulation of cellular signaling, migration, apoptosis, and cell cycle progression. Previous reports have shown that FAK is expressed in various kinds of cancer tissues and cancer cell lines; however, no information is available about human pancreatic carcinoma specimens. Tissue such specimens were obtained from 50 patients who underwent pancreatic resection for pancreatic invasive ductal carcinoma at our institute from 1996 to 2002. Immunohistochemical analysis of FAK was performed in the resected specimens. Focal adhesion kinase expression in seven human pancreatic cancer cell lines was analyzed by reverse transcription polymerase chain reaction (PCR) analysis and Western blot analysis. Focal adhesion kinase expression was detected in 24 of 50 cases (48%). There was a statistically significant correlation between FAK expression and tumor size (P = 0.004), although FAK expression did not significantly correlate with other factors such as tumor histological grade, lymph node metastasis, distant metastasis, histological stage, and overall survival. Reverse transcription PCR analysis and Western blot analysis showed that FAK was expressed in all seven pancreatic cancer cell lines. Focal adhesion kinase expression was not directly related to clinicopathological factors except tumor size in pancreatic carcinoma. Focal adhesion kinase expression may not be a prognostic marker for pancreatic cancer patients.Funding Information
- Ministry of Education, Culture, Sports, Science and Technology (17390364, 17659409)
This publication has 30 references indexed in Scilit:
- Focal adhesion kinase gene silencing promotes anoikis and suppresses metastasis of human pancreatic adenocarcinoma cellsSurgery, 2004
- Characterization of an activated mutant of focal adhesion kinase: ‘SuperFAK’Biochemical Journal, 2002
- Increased dosage and amplification of the focal adhesion kinase gene in human cancer cellsOncogene, 1999
- Focal adhesion kinase promotes phospholipase C-γ1 activityProceedings of the National Academy of Sciences of the United States of America, 1999
- Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancerAnnals of Surgical Oncology, 1996
- Association of focal adhesion kinase with its potential substrate phosphatidylinositol 3-kinase.Proceedings of the National Academy of Sciences of the United States of America, 1994
- Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of vater—results of a controlled, prospective, randomised multicentre studyEuropean Journal of Cancer, 1993
- pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions.Proceedings of the National Academy of Sciences of the United States of America, 1992
- Survival After PancreatoduodenectomyAnnals of Surgery, 1990